Alcohol Use Disorders Clinical Trial
Official title:
The Effect of an Interdisciplinary "Booster" Session in Primary Care Following Brief Intervention in Hospitals - a Randomized Clinical Trial
The effect of alcohol interventions seems to be related to the intensity of the interventions. In this study the investigators will assess the effect of a interdisciplinary "booster session" in primary care, given to patients who were admitted to hospitals with alcohol related conditions, and who were given Brief Intervention before discharge. The booster session is based on a motivational interview.
Status | Recruiting |
Enrollment | 120 |
Est. completion date | December 2012 |
Est. primary completion date | December 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Admission with an alcohol related disorder Exclusion Criteria: - Lack of ability to give informed consent |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Norway | Stavanger University Hospital | Stavanger |
Lead Sponsor | Collaborator |
---|---|
Helse Stavanger HF |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Alcohol Use Disorder Identification -C (AUDIT-C) | Alcohol Use Disorder Identification -C. Dicothomous outcome. More or less than four points for women and five points for men. | 6 months | No |
Secondary | Timeline followback | Grams og alcohol pr week. | 6 months | No |
Secondary | Readmissions | Readmission to a hospital for an alcohol related and/or a non-alcohol related condition within six months after discharge. | 6 months | No |
Secondary | Readiness to Change Questionaire (RTCQ) | Continous variable | 6 months | No |
Secondary | Quality of Life | SF 12 | 6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02113618 -
Effect of Cognitive Training on Alcohol Use Outcomes
|
N/A | |
Completed |
NCT01008280 -
Baclofen to Reduce Alcohol Use in Veterans With HCV
|
Phase 4 | |
Active, not recruiting |
NCT02671019 -
Effectiveness and Costs of Internet-based Treatment for Harmful Alcohol Use and Face-to-face Treatment in Addiction Care
|
N/A | |
Completed |
NCT01751035 -
Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD
|
N/A | |
Active, not recruiting |
NCT03695653 -
Messaging Interventions to Reduce Alcohol Problems Project
|
N/A | |
Completed |
NCT02298751 -
Exposure Therapy as Aftercare for Alcohol Use Disorder
|
N/A | |
Terminated |
NCT01566370 -
Zonisamide for Heavy Drinkers With Bipolar Disorder
|
Phase 2 | |
Completed |
NCT01642381 -
Component Analysis for Motivational Interviewing
|
N/A | |
Completed |
NCT02384278 -
Internet Based Cognitive Behavior Treatment for Alcohol Problems
|
N/A | |
Completed |
NCT02511808 -
Adaptive Interventions for Problem Drinkers
|
N/A | |
Completed |
NCT01613014 -
ABT-436 for Alcohol Dependence
|
Phase 2 | |
Completed |
NCT02905162 -
Understanding Longitudinal Clinical Outcomes and Post-release Retention in Care Among HIV-infected Prisoners in Lusaka, Zambia
|
||
Completed |
NCT02808468 -
Brief Restructuring Intervention Following Trauma Exposure
|
N/A | |
Completed |
NCT01692054 -
Risk and Protective Factors of Children and Adolescents Who Were Hospitalized Due to Alcohol Intoxication
|
N/A | |
Completed |
NCT02500602 -
CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders
|
Phase 2 | |
Active, not recruiting |
NCT02713217 -
Implementing a Blended Care Model That Integrates Mental Healthcare and Primary Care Using Telemedicine and Care Management for Patients With Depression or Alcohol Use Disorder in Small Primary Care Clinics
|
||
Recruiting |
NCT02465177 -
Tailoring Screening, Brief Intervention, and Referral to Treatment for Medical ICU Survivors
|
||
Completed |
NCT02193256 -
Varenicline + Prazosin for Heavy Drinking Smokers
|
Early Phase 1 | |
Completed |
NCT01172210 -
Examining Common Substrates of Eating and Alcohol Use Disorders
|
N/A |